Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia

( views:, downloads: )
Author:
()
()
()
()
()
()
()
()
()
()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 56, Issue 05, 2004
DOI:
Key Word:

Abstract´╝Ü

  • [1]Goldstein JL, Brown MS, Hobbs HH. Familial hypercholesterolemia. In:Scriver CR, Beaudet AL, Sly WS,Valle D. edtors. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw Hill, 1995:1981-2030.
  • [2]Morash BA, Tan MH, Nassar BA, Too CKL,Guernsey DL.A novel mutation in Exon4 of the low density lipoprotein receptor gene resulting in heterozygous familial hypercholesterolemia associated with decreased ligand binding. Atherosclerosis 1998;136: 9-16.
  • [3]Calandra S, Defesche J, Faergeman O, Craig IH, Hayden M, Kastelein J. In: Boulyjenkov V, Nordet P, Richstein K.Familial Hypercholesterolemia (FH). Report of a WHO Consultation, Geneva 1998: 1-68.
  • [4]Vergopoulos A, Knoblauch H, Schuster H. DNA testing for familial hypercholesterolemia: improving disease recognition and patient care. Am J Pharmacogen 2002;2(4):253-262.
  • [5]Marks D, Thorogood M, Neil AW, Humphries SE. A review on the diagnosis, nature history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003; 168:1-14.
  • [6]Lambardi P, de Wit E, Frannts RR, Havekes LM. Characterization of the LDL receptor in Epstein-Barr virus-transformed lymphocytes. Biochim Biophys Acta 1990; 1044:127-132.
  • [7]Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-1353.
  • [8]Pitas RE, Innerarity TL, Weinstein JN, Mahley RW.Acetoacetylated LDL used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1981; 1:177-185.
  • [9]Chan PA, Jones C, Lafreniere R, Lafreniere R, Parsons HG. Surface expression of low density lipoprotein receptor in EBV-transformed lymphocyte: Characterization and use for studying familial hypercholesterolemia. Atheroslerosis 1997;131:149-160.
  • [10]Verhoeye FR, Descamps O ,Husson B, Hondekijn JC, Ronveaur-Dupal MF, Lontie JF, Heller FR. An improved method for detection of low density lipoprotein receptor defects in human T lymphocytes. J Lipid Res 1996; 37:1377-1384.
  • [11]Villeger L, Abifadel M, Allard D, Rabes JP, Thiart R, Kotze MJ, Beroud C, Junien C,Boilean C and Varret M. The UMDLDLR Database: Addition to the software and 490 new entries to the database. Hum Mutat 2002;20(2):81-87.
  • [12]Ose L. Familial hypercholesterolemia from children to adults.Cardiovasc Drugs Ther 2002; 16:289-293.
  • [13]Yamamoto T, Davis CG, Brown MS,Schneider WJ,Casey ML, Goldstein JL,Russell DW. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984; 39: 27-38.
  • [14]Wang DQ, Wu BQ, Li Y, Heng W, Zhong H, Mu Y, Wang J.A Chinese homozygous of familial hypercholesterolemia:identification of a novel C263R mutation in the LDL receptor gene. J Hum Genet 2001; 46: 152-154.
  • [15]Myant NB, Gallagher JJ, Knight BL, McCarthy SN,Frostegard J,Nisson J. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.Arterioscler Thromb 1991; 11:691-703.
  • [16]Stephan ZF, Yurachek EC. Rapid flurorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res 1993; 34:325-330.
  • [17]Brodff SW, Glade PR, Hirschtiorn K. Establishment of longterm lines from small aliquots of normal lymphocytes. Blood 1970; 35(4):539-542.
  • [18]Glade PR, Beratis NG. Long term lymphoid cell lines in the study of human genetics. Pro Med Genet 1976; 1:148.
  • [19]Chan P, Jones C,Lafreniere R, Parsons HG. Surface expression of low density lipoprotein receptor in EBV-transformed lymphocytes: characterization and use for studying familial hypercholesterolemia. Atherosclerosis 1997; 131: 149-160.
  • [20]Brack C. Cyclosporin A is a differential inhibitor of eukaryotic RNA polymerases. Exp Cell Res 1984; 151:314.
  • [21]Lombardi P, de Wit E, Frants RR, Havekes LM. Characterization of the LDL receptor in Epstein-Barr virus-transformed lymphocytes.Biochim Biophys Acta 1990; 1044:127-132.
  • [22]Schmitz G, Bruning T ,Kovacs E, Barlage S. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscler Thromb 1993; 13:1053-1065.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn